CA: 90% of Injured Workers’ Treatment Appeals Fail. Why?

CA: 90% of Injured Workers’ Treatment Appeals Fail. Why?

In 2025, injured workers in California appealed payers’ decisions to deny or modify 266,756 treatments recommended by their physicians. Those appeals failed for 90% of the requested treatments.

Those figures do not include appeals that the California Division of Workers’ Compensation (CA DWC) deemed duplicate submissions or otherwise ineligible for Independent Medical Review (IMR), the process by which an independent contractor, Maximus, determines whether to overturn a payer’s treatment denial.

By contrast, independent research shows that appeals of prior authorization decisions in Medicare Advantage plans are successful the vast majority of the time, in one study exceeding 80% each year from 2019 to 2024.

By itself, a 10% success rate for treatment appeals in California workers’ comp is objectively concerning, and arguably implausible. But compared to the relatively high success rates in other health systems, it’s borderline scandalous.

CA Comp: 90% of Treatment Appeals Fail

According to the CA DWC’s most recent official IMR report, in 2025 injured workers submitted 167,692 “unique” (i.e., non-duplicate) IMR applications, through which they hoped to overturn payers’ Utilization Review (UR) decisions denying or modifying care.

Of those, the CA DWC deemed 152,832 applications eligible for IMR.

Eligible IMR requests collectively accounted for 266,756 individual treatments that doctors submitted to payers for approval. Maximus overturned the payer’s decision and approved just 10.2% of those treatments.

The 2025 numbers are consistent with previous years’ data. Since 2016, IMR has failed to overturn between 87% and 93% of treatment decisions, depending on the year.

The CA DWC does not publish statistics on the percentage of UR decisions that injured workers appeal (nor could it, considering the agency’s failure, in violation of state law, to establish a UR reporting system).  We’ll leave it to our readers to decide how likely it is that about 90% of the time, when an injured worker undertakes the IMR process, the treatment their doctor requested is somehow invalid.

Our own workers’ comp data strongly suggest that inappropriate treatment denials are a problem.

Data from daisyAuth show that year after year, the payers in our system issue UR decisions approving the requested treatment roughly 70% of the time. More to the point, denial rates varied widely across payers; in 2024, for example, denial rates ranged from the single digits to 46%.

In our view, it’s apparent that treatment approval depends, to a disturbing degree, on the payer making the decision rather than on medical necessity or appropriateness (with the nation’s largest Third-Party Administrator providing the most obnoxious example).

Appeals In Other Systems Overwhelmingly Succeed

IMR data look even more suspect when compared with available appeal data from other systems, such as Medicare Advantage plans.

Medicare Advantage plans (which are privately run despite carrying the “Medicare” moniker) have made headlines for impeding care through prior authorization requirements. Functionally, prior authorization is no different from UR, with one crucial exception: patients who appeal prior authorization decisions in Medicare Advantage plans tend to win.

A former Chief Medical Officer for UnitedHealthcare reviewed prior authorization data on Medicare Advantage plans under both United and Humana, and found that the majority of appeals against those denials were successful. In 2025, 58% of appeals against United’s denials succeeded, as well as 65% of appeals against Humana denials.

Zooming out from United and Humana to look at Medicare Advantage plans broadly, KFF found that patients win their appeals even more frequently. Every year from 2019 to 2024, Medicare Advantage patients’ appeals succeeded, partially or fully, more than 80% of the time, peaking at 83.2% in 2022.

Workers’ comp is different from other health systems. That acknowledged, there is no plausible explanation that we’ve seen for why treatment denials in Medicare Advantage and other systems are so overwhelmingly successful, while successful IMR appeals are such rarities.  

It’s just one compelling reason among many why California workers’ comp stakeholders should demand that the CA DWC, under its new leadership, do what previous agency leadership failed to do: follow the law and establish a centralized, publicly maintained database of all UR decisions.

Until California has the necessary visibility into treatment approval and denial in workers’ comp, injured workers will almost surely be deprived of the care they need.


Submit compliant Requests for Authorization (and automatically track payers’ responses) with daisyAuth:

DAISYAUTH: EASY RFAs

0 Reader Comments
There are no comments for this article. Be the first to comment!

DaisyBill provides content as an insightful service to its readers and clients. It does not offer legal advice and cannot guarantee the accuracy or suitability of its content for a particular purpose.